Passive protection of shrimp against white spot syndrome virus (WSSV) using specific antibody from egg yolk of chickens immunized with inactivated virus or a WSSV-DNA vaccine

Fish and Shellfish Immunology

Volumn 25, Issue 5, 2008, Pages 604-610

  Lu, Yanan ^a   Liu, Junjun ^a   Jin, Liji ^a   Li, Xiaoyu ^a   Zhen, YuHong ^a   Xue, Hongyu ^a   You, Jiansong ^a   Xu, Yongping ^a,b  

^a DALIAN UNIVERSITY OF TECHNOLOGY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

CpG ODNs; DNA vaccine; IgY; Inactivated vaccine; Linker; White spot syndrome virus

Indexed keywords

DECAPODA (CRUSTACEA); GALLUS GALLUS; METAPENAEUS ENSIS; SHRIMP WHITE SPOT SYNDROME VIRUS;

EID: 54849436608     PISSN: 10504648     EISSN: 10959947     Source Type: Journal    
DOI: 10.1016/j.fsi.2008.08.010     Document Type: Article

References (47)

1. Wongteerasupaya C., Vicker J.E., Sriurairatana S., Nash G.L., Akarajamorn A., Tassanakajon A., et al. A non-occluded, systemic baculovirus that occurs in cells of ectodermal and mesodermal origin and causes high mortality in the black tiger prawn, Penaeus monodon. Dis Aquat Organ 21 (1995) 69-77
2. Wang Y.C., Lo C.F., Chang P.S., and Kou G.H. Experimental infection of white spot baculovirus in some cultured and wild decapods in Taiwan. Aquaculture 164 (1998) 221-231
3. Lo C.F., Ho C.H., Peng S.E., Chen C.H., Hsu H.C., Chiu Y.L., et al. White spot syndrome baculovirus (WSBV) detected in cultured and captured shrimp, crabs and other arthropods. Dis Aquat Organ 27 (1996) 215-225
4. Rosenberg R. World shrimp farming 2000. Shrimp News Int 13 (2000) 1-324
5. Yang F., Wang W., Chen R., and Xu X. A simple and efficient method for purification of prawn baculovirus DNA. J Virol Methods 67 (1998) 1-4
6. Durand S., Lightner D.V., Redman R.M., and Bonami J.R. Ultrastructure and morphogenesis of white spot syndrome baculovirus (WSSV). Dis Aquat Organ 29 (1997) 205-211
7. Nadala E.C.B., Tapay L.M., and Loh P.C. Characterization of a non-occluded baculovirus-like agent pathogenic to penaeid shrimp. Dis Aquat Organ 33 (1998) 221-229
8. Van Hulten M.C.W., Witteveldt J., Snippe M., and Vlak J.M. White spot syndrome virus envelope protein VP28 is involved in the systemic infection of shrimp. Virology 285 (2001) 228-233
9. Van Hulten M.C.W., Reijns M., Vermeesch A.M.G., Zandberge F., and Vlak J.M. Identification of VP19 and VP15 of white spot syndrome virus (WSSV) and glycosylation status of the WSSV major structural proteins. J Gen Virol 83 (2002) 257-265
10. Robalino J., Payne G., Parnell P., Shepard E., Grimes A.C., Metz A., et al. Inactivation of White Spot Syndrome Virus (WSSV) by normal rabbit serum: Implications for the role of the envelope protein VP28 in WSSV infection of shrimp. Virus Res 118 (2006) 55-61
11. Witteveldt J., Vermeesch A.M.G., Langenhof M., de Lang A., Vlak J.M., and Van Hulten M.C.W. Nucleocapsid protein VP15 is the basic DNA binding protein of white spot syndrome virus of shrimp. Arch Virol 150 (2005) 1121-1133
12. Kimbrell D.A., and Beutler B. The evolution and genetics of innate immunity. Nat Rev Genet 2 (2001) 256-267
13. Yoganandhan K., Musthaq S.S., Narayanan R.B., and Sahu Hameed A.S. Production of polyclonal antiserum against recombinant VP28 protein and its application for the detection of white spot syndrome virus in crustaceans. J Fish Dis 27 (2004) 517-522
14. Kim D.K., Jang I.K., Seo H.C., Shin S.O., Yang S.Y., and Kim J.W. Shrimp protected from WSSV disease by treatment with egg yolk antibodies (IgY) against a truncated fusion protein derived from WSSV. Aquaculture 237 (2004) 21-30
15. Li H.X., Meng X.L., Xu J.P., Lu W., and Wang J. Protection of crayfish, Cambarus clarkii, from white spot syndrome virus by polyclonal antibodies against a viral envelope fusion protein. J Fish Dis 28 (2005) 285-291
16. Zhang W.-W. The use of gene-specific IgY antibodies for drug target discovery. Drug Discov Datay 8 (2003) 364-371
17. Nikoo A., Aminirissehei A.-H., Yousif A.N., Albright L.J., and Durance T.D. Passive immunization of rainbow trout(Oncorhynchus mykiss) with chicken egg yolk immunoglobulins (IgY). Aquaculture 231 (2004) 23-36
18. Cova L. DNA-designed avian IgY antibodies: novel tools for research, diagnostics and therapy. J Cli Virol 34 (2005) 70-74
19. Brave A., Ljungberg K., Boberg A., Rollman E., Isaguliants M., Lundgren B., et al. Multigene/multisubtype HIV-1 vaccine induces potent cellular and humoral immune responses by needle-free intradermal delivery. Mol Ther 12 (2005) 1197-1202
20. Otten G.R., Schaefer M., Doe B., Liu H., zur Megede J., et al. Potent immunogenicity of an HIV-1 gag-pol fusion DNA vaccine delivered by in vivo electroporation. Vaccine 24 (2006) 4503-4509
21. Argos P. An investigation of oligopeptides linking domains in protein tertiary structures and possible candidates for general gene fusion. J Mol Biol 211 (1990) 943-958
22. Chiquito J.C., and Feng J. Linker: a program to generate linker sequences for fusion proteins. Protein Eng 13 (2000) 309-312
23. George R.A., and Heringa J. An analysis of protein domain linkers: their classification and role in protein folding. Protein Eng 15 (2003) 871-879
24. Natividad K.D.T., Hagio M., Tanaka M., Nomura N., and Matsumura M. White spot syndrome virus (WSSV) inactivation in Penaeus japonicus using purified monoclonal antibody targeting viral envelope protein. Aquaculture 269 (2007) 54-62
25. Li J., Huang Y., Liang X., Lu M., Li L., Yu L., et al. Plasmid DNA encoding antigens of infectious bursal disease viruses induce protective immune responses in chickens: factors influencing efficacy. Virus Res 98 (2003) 63-74
26. Abouzid K., Ndeboko B., Durantel S., Jamard C., Zoulim F., Buronfosse T., et al. Genetic vaccination for production of DNA-designed antibodies specific to Hepadnavirus envelope proteins. Vaccine 24 (2006) 4615-4617
27. Krieg A.M. Mechanisms and applications of immune stimulatory CpG oligodeoxynucleotides. Biochim Biophys Acta 1489 (1999) 107-116
28. Ameiss K.A., Attrache J.E., Barri A., McElroy A.P., and Caldwell D.J. Influence of orally administered CpG-ODNs on the humoral response to bovine serum albumin (BSA) in chickens. Vet Immunol Immunopathol 110 (2006) 257-267
29. Hartmann G., Weeratna R.D., Ballas Z.K., Payette P., Blackwell S., Suparto I., et al. Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo. Immunol 164 (2000) 1617-1624
30. Rankin R., Pontarollo R., Ioannou X., Krieg A.M., Hecker R., Babiuk L.A., et al. CpG motif identification for veterinary and laboratory species demonstrates that sequence recognition is highly conserved. Antisense Nucleic Acid Drug Dev 11 (2001) 333-340
31. Shevchuk N.A., Bryksin A.V., Nusinovich Y.A., Cabello F.C., Sutherland M., and Ladisch S. Construction of long DNA molecules using long PCR-based fusion of several fragment simultaneously. Nucleic Acids Res 32 (2004) 19-47
32. Wu J.L., Nishioka T., Mori K., Nishizawa T., and Muroga K. A time-course study on the resistance of Penaeus japonicus induced by artificial infection with white spot syndrome virus. Fish Shellfish Immunol 13 (2002) 391-403
33. Witteveldt J., Vlak J.M., and van Hulten M.C.W. Protection of Penaeus monodon against white spot syndrome virus using a WSSV subunit vaccine. Fish Shellfish Immunol 16 (2004) 571-579
34. Rout N., Kumar S., Jaganmohan S., and Murugan V. DNA vaccines encoding viral envelope proteins confer protective immunity against WSSV in black tiger shrimp. Vaccine 25 (2007) 2778-2786
35. Mine Y., and Kovacs-Nolan J. Immunotherapeutic potential of antibodies produced in chicken eggs. In: Erickson L., Wu W.J., Brandle J., and Rymerson R. (Eds). Molecular farming of plants for human and veterinary medicine (2002), Kluwer Academic, Dordrecht, Netherlands 287-317
36. Kweon C.H., Kwon B.J., Woo S.R., Kim J.M., Woo G.H., Son D.H., et al. Immunoprophylactic effect of chicken egg yolk immunoglobulin (IgY) against porcine epidemic diarrhea virus (PEDV) in piglets. J Vet Med Sci 62 (2000) 961-964
37. Arasteh N., Aminirissehei A.H., Yousif A.N., Albright L.J., and Durance T.D. Passive immunization of rainbow trout (Oncorhynchus mykiss) with chicken egg yolk immunoglobulins (IgY). Aquaculture 231 (2004) 23-36
38. Gaudreau M.C., Lacasse P., and Talbot B.G. Protective immune responses to a multi-gene DNA vaccine against Staphylococcus aureus. Vaccine 25 (2007) 814-824
39. Woo J.H., Liu Y.Y., Mathias A., Stavrou S., Wang Z., Thompson J., et al. Gene optimization is necessary to express a bivalent anti-human anti-T cell immunotoxin in Pichia pastoris. Protein Exp Purif 25 (2002) 270-282
40. 3 linker sequence results in enhanced protein expression. Mol Immunol 40 (2004) 717-722
41. Sakaguchi M., Nakamura H., Sonoda K., Hamada F., and Hirai K. Protection of chickens from Newcastle disease by vaccination with a linear plasmid DNA expressing the F protein of Newcastle disease virus. Vaccine 14 (1996) 747-752
42. Hulse D.J., and Romero C.H. Partial protection against infectious bursal disease virus through DNA-mediated vaccination with the VP2 capsid protein and chicken IL-2 genes. Vaccine 22 (2004) 1249-1259
43. Wu C.N., Lin Y.C., Cathy F., Liao S.N., Shi S.R., and Ho M.S. Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus. Vaccine 20 (2002) 895-904
44. Dorya D., Beven V., Torche A.M., Bougeard S., Cariolet F., and Jestin A. CpG motif in ATCGAT hexamer improves DNA-vaccine efficiency against lethal Pseudorabies virus infection in pigs. Vaccine 23 (2005) 4532-4540
45. Weeratna R.D., McCluskie M.J., Xu Y., and Davis H.L. CpG DNA induces stronger immune responses with less toxicity than other adjuvants. Vaccine 18 (2000) 1755-1762
46. Otake S., Nishihara Y., Makimura M., Hatta H., Kim M., and Yamamoto T. Protection of rats against dental caries by passive immunization with hen-egg-yolk antibody (IgY). J Dental Res 70 (1991) 162-166
47. Chang H.M., Lee Y.C., Chen C.C., and Tu Y.Y. Microencapsulation protects immunoglobulin in yolk (IgY) specific against Helicobacter pylori urease. J Food Sci 67 (2002) 15-20